You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

wAMD

Showing 26 - 50 of 75
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Wet Age-related Macular Degeneration or Diabetic Macular Edema

Completed
  • Macular Degeneration
  • Eylea (Aflibercept, VEGF Trap-Eye, BAY86-5321)
  • Multiple Locations, Argentina
  • +3 more
Jun 24, 2021

Neovascular Age-related Macular Degeneration Trial in Katy, Norfolk (SKG0106)

Not yet recruiting
  • Neovascular Age-related Macular Degeneration
  • SKG0106
  • Katy, Texas
  • +1 more
Aug 15, 2023

Macular Degeneration Trial in Worldwide (Ranibizumab)

Completed
  • Macular Degeneration
  • Ranibizumab
  • Gilbert, Arizona
  • +101 more
Mar 11, 2022

Neovascular Age-related Macular Degeneration(nAMD) Trial in Shanghai, Tianjin (HG202)

Not yet recruiting
  • Neovascular Age-related Macular Degeneration(nAMD)
  • HG202
  • Shanghai, Shanghai, China
  • +1 more
Sep 4, 2023

Geographic Atrophy and Their Patient Journey in United States

Not yet recruiting
  • Geographic Atrophy
    • (no location specified)
    May 26, 2023

    Neovascular Age-related Macular Degeneration Trial in United States (ADVM-022)

    Recruiting
    • Neovascular Age-related Macular Degeneration
    • ADVM-022
    • Phoenix, Arizona
    • +4 more
    Sep 8, 2022

    Age-related Wet Macular Degeneration Trial in United States (CG-P5 peptide, Placebo, Aflibercept Injection [Eylea])

    Not yet recruiting
    • Age-related Wet Macular Degeneration
    • CG-P5 peptide
    • +2 more
    • Augusta, Georgia
    • +3 more
    Nov 13, 2023

    Wet Macular Degeneration Trial in Prague (Aflibercept 40 MG/ML [Eylea], Brolucizumab-Dbll 120 MG/ML [Beovu], Ranibizumab 6 MG/ML

    Withdrawn
    • Wet Macular Degeneration
    • Aflibercept 40 MG/ML [Eylea]
    • +2 more
    • Prague, Czechia
      Department of Ophthalmology, Faculty hospital Kralovske Vinohrad
    Aug 7, 2022

    Intravitreal Aflibercept in Wet Macular Degeneration in Greece

    Completed
    • Choroidal Neovascularization
    • Macular Degeneration
    • Aflibercept (Eylea, BAY86-5321)
    • Multiple Locations, Greece
      Many Locations
    Nov 23, 2020

    Wet Age-related Macular Degeneration, Neovascular Age-related Macular Degeneration Trial in United States (ADVM-022)

    Active, not recruiting
    • Wet Age-related Macular Degeneration
    • Neovascular Age-related Macular Degeneration
    • ADVM-022
    • Bakersfield, California
    • +10 more
    Mar 21, 2022

    Age-related Macular Degeneration Trial in Beijing (BAT5906 injection)

    Completed
    • Age-related Macular Degeneration
    • BAT5906 injection
    • Beijing, China
      Peking Union Medical College Hospital, Chinese Academy of Medica
    Sep 22, 2021

    Neovascular (Wet) Age-Related Macular Degeneration Trial in United States (4D-150 IVT, Aflibercept IVT)

    Recruiting
    • Neovascular (Wet) Age-Related Macular Degeneration
    • 4D-150 IVT
    • Aflibercept IVT
    • Oxnard, California
    • +9 more
    Jun 13, 2022

    Maximum Treatment Interval With Aflibercept T&E

    Recruiting
    • Neovascular Age-related Macular Degeneration
    • Aflibercept Injection [Eylea]
    • Taipei, Taiwan
      Shin Kong Memorial Wu Ho-Su Hospital
    Apr 19, 2022

    Neovascular Age-Related Macular Degeneration (nAMD) Trial in United States (RGX-314 Dose 1, RGX-314 Dose 2, Ranibizumab

    Recruiting
    • Neovascular Age-Related Macular Degeneration (nAMD)
    • RGX-314 Dose 1
    • +3 more
    • Phoenix, Arizona
    • +14 more
    Mar 29, 2022

    Long-term Study of ADVM-022 in Neovascular (Wet) AMD [OPTIC-EXT]

    Enrolling by invitation
    • Wet Age-related Macular Degeneration
    • Neovascular Age-related Macular Degeneration
    • ADVM-022
    • Bakersfield, California
    • +8 more
    Dec 23, 2021

    Intravitreal Aflibercept and to Describe Follow-up as Well as

    Completed
    • Wet Macular Degeneration
    • Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)
    • Multiple Locations, Canada
      (unnamed)
    Feb 14, 2019

    Neovascular Age-related Macular Degeneration, Wet Macular Degeneration, Wet Age-related Macular Degeneration Trial in United

    Recruiting
    • Neovascular Age-related Macular Degeneration
    • +2 more
    • RGX-314
    • Phoenix, Arizona
    • +12 more
    Oct 12, 2021

    Retinal Health Monitoring System Thickness Module

    Completed
    • Macular Edema
    • Macular Degeneration
    • RHMS-RTM
    • SD-OCT
    • Bern, Switzerland
      Inselspital, University Hospital Bern, Department of Ophthalmolo
    Feb 16, 2021

    Exudative Macular Degeneration, Wet Age-related Macular Degeneration Trial in Iowa City (Doxycycline Hyclate, Placebo)

    Recruiting
    • Exudative Macular Degeneration
    • Wet Age-related Macular Degeneration
    • Doxycycline Hyclate
    • Placebo
    • Iowa City, Iowa
      University of Iowa Hospitals & Clinics Department of Ophthalmolo
    Apr 5, 2022

    Intravitreal Aflibercept in Routine Clinical Practice Based on

    Completed
    • Macular Degeneration
    • Eylea (Aflibercept, VEGF Trap-Eye, BAY86-5321)
    • Multiple Locations, Germany
      Many locations
    Jan 8, 2020

    Wet Macular Degeneration Trial in Barcelona (0.5mg aflibercept)

    Completed
    • Wet Macular Degeneration
    • 0.5mg aflibercept
    • Barcelona, Spain
      Barcelona Macula Foundation
    Nov 21, 2018

    Neovascular Age-related Macular Degeneration Trial in Beijing (RC28-E)

    Completed
    • Neovascular Age-related Macular Degeneration
    • RC28-E
    • Beijing, China
      Beijing Tongren Hospital .Cmu
    Apr 26, 2021

    Artificial Intelligence Diagnostic Aid

    Not yet recruiting
    • Wet Macular Degeneration
    • +2 more
    • Macusense Assessment Software
    • London, Westminster, United Kingdom
      Guy's and St Thomas's NHS Foundation Trust
    Dec 29, 2022

    Study for Collection of Aflibercept Data in Routine Practice

    Completed
    • Eye Diseases
    • Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)
    • Multiple Locations, France
      (unnamed)
    Jul 1, 2019

    UtilizingTele-Retinal Referral System for wAMD and DME: A Pilot

    Unknown status
    • Wet Age Related Macular Degeneration
    • Diabetic Macular Edema
      • Hamilton, Ontario, Canada
        St. Joseph's Healthcare Hamilton King Campus
      Apr 5, 2018